| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| KGKestrel Group, Ltd. | 73.01M | 9.43 | -0.23 | 294.7% | -370.55% | -70.78% | 5.65 | |
| OXBROxbridge Re Holdings Limited | 9.42M | 1.23 | -2.73 | 107.75% | -128.35% | -45.24% | 0.06 |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Revenue | 186.59M | 98.72M | 58.13M | 1.33M | 5.25M |
| Revenue Growth % | - | -0.47% | -0.41% | -0.98% | 2.95% |
| Medical Costs & Claims | 0 | 0 | 0 | 3.53M | 3.4M |
| Medical Cost Ratio % | - | - | - | - | - |
| Gross Profit | 186.59M | 98.72M | 58.13M | -2.2M | 1.85M |
| Gross Margin % | - | - | - | - | - |
| Gross Profit Growth % | - | -0.47% | -0.41% | -1.04% | 1.84% |
| Operating Expenses | 0 | 0 | 0 | 2.25M | 1.71M |
| OpEx / Revenue % | - | - | - | - | - |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Combined Ratio % | - | - | - | - | - |
| Operating Income | 66.88M | 30.55M | -49.32M | -4.45M | 141.76K |
| Operating Margin % | - | - | - | - | - |
| Operating Income Growth % | - | -0.54% | -2.61% | 0.91% | 1.03% |
| EBITDA | 55.88M | 38.24M | -41.06M | -4.45M | 141.76K |
| EBITDA Margin % | - | - | - | - | - |
| Interest Expense | 19.32M | 19.33M | 19.33M | 0 | 0 |
| Non-Operating Income | 10.99M | -7.68M | -8.26M | 0 | 0 |
| Pretax Income | 41.66M | 26.66M | -60.6M | -4.22M | 354.31K |
| Pretax Margin % | - | - | - | - | - |
| Income Tax | -104K | 15K | -557K | 0 | 30.04K |
| Effective Tax Rate % | - | - | - | - | - |
| Net Income | 41.76M | 25.62M | -60.35M | -4.22M | 324.27K |
| Net Margin % | - | - | - | - | - |
| Net Income Growth % | - | -0.39% | -3.36% | 0.93% | 1.08% |
| EPS (Diluted) | 18.96 | 27.10 | 12.65 | -0.55 | -40.23 |
| EPS Growth % | - | 0.43% | -0.53% | -1.04% | -72.15% |
| EPS (Basic) | 18.96 | 27.10 | 12.65 | -0.55 | -40.23 |
| Diluted Shares Outstanding | 4.22M | 4.3M | 4.36M | 7.7M | 5M |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Total Assets | 2.95B | 2.32B | 1.85B | 954.6M | 4.7M |
| Asset Growth % | - | -0.21% | -0.2% | -0.48% | -1% |
| Total Investment Assets | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 1.5B | 1.36B | 1.13B | 5.59M | 4.47M |
| Cash & Equivalents | 135.83M | 66.09M | 46.62M | 5.55M | 4.29M |
| Receivables | 0 | 0 | 0 | 0 | 153.94K |
| Other Current Assets | 1.5B | 1.36B | 1.07B | 37.31K | 33.16K |
| Goodwill & Intangibles | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| PP&E (Net) | 0 | 0 | 0 | 292.33K | 223.46K |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 2.42B | 1.94B | 1.56B | 705.44M | 699.48M |
| Total Debt | 255.13M | 255.35M | 255.57M | 314K | 255.28M |
| Net Debt | 119.3M | 189.26M | 208.95M | -5.24M | 250.99M |
| Long-Term Debt | 255.13M | 255.35M | 255.57M | 254.6M | 254.76M |
| Short-Term Debt | 0 | 0 | 0 | 201K | 277K |
| Total Current Liabilities | 1.95B | 1.53B | 1.19B | 2.23M | 735.91K |
| Accounts Payable | 0 | 0 | 0 | 1.72M | 298.65K |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.95B | 1.53B | 1.19B | 236.28K | 84.77K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | -330.07M | -304.31M | -303.28M | -327.86M | -363.64M |
| Total Equity | 527.82M | 384.26M | 284.58M | 249.16M | 45.19M |
| Equity Growth % | - | -0.27% | -0.26% | -0.12% | -0.82% |
| Shareholders Equity | 527.82M | 384.26M | 284.58M | 249.16M | 45.19M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -615.84M | -498.3M | -442.86M | -486.94M | -687.91M |
| Common Stock | 898K | 923K | 1.49M | 1.5M | 1.5M |
| Accumulated OCI | 23.86M | -12.21M | -41.23M | -6.67M | -32.73M |
| Return on Equity (ROE) | 0.08% | 0.06% | -0.18% | -0.02% | 0% |
| Return on Assets (ROA) | 0.01% | 0.01% | -0.03% | -0% | 0% |
| Equity / Assets | - | - | - | - | - |
| Debt / Equity | 0.48x | 0.66x | 0.90x | 0.00x | 5.65x |
| Book Value per Share | 125.17 | 89.29 | 65.33 | 32.35 | 9.05 |
| Tangible BV per Share | - | - | - | - | - |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Cash from Operations | -541.77M | -394.43M | -195.93M | -2.49M | -67.45M |
| Operating CF Growth % | - | 0.27% | 0.5% | 0.99% | -26.14% |
| Operating CF / Revenue % | - | - | - | - | - |
| Net Income | 41.76M | 25.62M | -60.35M | -4.22M | -200.97M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 59.7K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -9.89M | -18.84M | -2.71M | 66.41K | -19.87M |
| Working Capital Changes | -573.65M | -401.22M | -132.87M | 1.6M | 153.39M |
| Cash from Investing | 596.04M | 464.06M | 188.79M | 0 | 77.74M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 2.73M | 0 | 0 |
| Purchase of Investments | -532.07M | -367.29M | -191.87M | 0 | -565.15M |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 0 | 1000K |
| Other Investing | -608K | 396K | -88K | 0 | -328K |
| Cash from Financing | -30.13M | -138.9M | -10.98M | 0 | -3.73M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -30.13M | -138.74M | -10.99M | 0 | -3.73M |
| Stock Issued | 0 | 0 | 10K | 0 | 0 |
| Debt Issuance (Net) | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -166K | 0 | 0 | 0 |
| Net Change in Cash | 28.55M | -69.74M | -19.46M | -2.49M | -7.94M |
| Exchange Rate Effect | 1000K | -470K | -1000K | 0 | -1000K |
| Cash at Beginning | 107.28M | 135.83M | 66.09M | 8.04M | 42.68M |
| Cash at End | 135.83M | 66.09M | 46.62M | 5.55M | 34.73M |
| Free Cash Flow | -541.77M | -394.43M | -195.93M | -2.49M | -67.45M |
| FCF Growth % | - | 0.27% | 0.5% | 0.99% | -26.14% |
| FCF Margin % | - | - | - | - | - |
| FCF per Share | -128.48 | -91.65 | -44.98 | -0.32 | -13.5 |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Combined Ratio | 0% | 0% | 0% | 434.22% | 97.3% |
| Medical Cost Ratio | 0% | 0% | 0% | 265.05% | 64.8% |
| Return on Equity (ROE) | 7.91% | 5.62% | -18.05% | -1.58% | 0.22% |
| Return on Assets (ROA) | 1.42% | 0.97% | -2.9% | -0.3% | 0.07% |
| Equity / Assets | 17.9% | 16.54% | 15.41% | 26.1% | 962.2% |
| Book Value / Share | 125.17 | 89.29 | 65.33 | 32.35 | 9.05 |
| Debt / Equity | 0.48x | 0.66x | 0.90x | 0.00x | 5.65x |
| Revenue Growth | - | -47.09% | -41.11% | -97.71% | 294.7% |
Kestrel Group, Ltd. (KG) grew revenue by 294.7% over the past year. This is strong growth.
Kestrel Group, Ltd. (KG) reported a net loss of $101.8M for fiscal year 2024.
Kestrel Group, Ltd. (KG) has a return on equity (ROE) of 0.2%. This is below average, suggesting room for improvement.
Kestrel Group, Ltd. (KG) has a combined ratio of 97.3%. A ratio below 100% indicates underwriting profitability.